- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05066217
EPX-100 (Clemizole Hydrochloride) som supplerende terapi hos børn med Lennox Gastaut syndrom
Et 20-ugers multicenter, randomiseret, dobbeltblindet, placebokontrolleret, bevis på konceptforsøg med EPX-100 (Clemizole Hydrochloride) som supplerende terapi hos børn med Lennox-Gastaut syndrom
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCL (EPX-100) as adjunctive therapy in children and adult participants with Lennox-Gastaut syndrome (LGS).
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCl as adjunctive therapy in children and adult participants with LGS.
The study will consist of an Observational Period, a Double-Blind (DB) Period, and an optional Open-Label Extension (OLE) Period.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Fase 3
Kontakter og lokationer
Studiekontakt
- Navn: Juby Philip
- Telefonnummer: (302) 559-4320
- E-mail: clinicaltrials@harmonybiosciences.com
Undersøgelse Kontakt Backup
- Navn: Cindy Sandy
- Telefonnummer: (317) 258-7262
- E-mail: clinicaltrials@harmonybiosciences.com
Studiesteder
-
-
Arkansas
-
Little Rock, Arkansas, Forenede Stater, 72202
- Aktiv, ikke rekrutterende
- Arkansas Children's Hospital
-
-
California
-
Orange, California, Forenede Stater, 92868
- Aktiv, ikke rekrutterende
- UC Irvine Medical Center
-
-
Florida
-
Miami, Florida, Forenede Stater, 33136
- Rekruttering
- University of Miami Miller School of Medicine
-
Kontakt:
- Brett Alonso Cardenas
- Telefonnummer: 305-243-3100
- E-mail: bac301@med.miami.edu
-
Ledende efterforsker:
- Kamil Detyniecki, MD
-
Orlando, Florida, Forenede Stater, 32804
- Rekruttering
- AdventHealth Innovation Tower
-
Ledende efterforsker:
- Holly Skinner, DO
-
Orlando, Florida, Forenede Stater, 34746
- Suspenderet
- Rare Disease Research
-
Winter Park, Florida, Forenede Stater, 32789
- Aktiv, ikke rekrutterende
- Pediatric Neurology and Epilepsy Specialists
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60611
- Rekruttering
- Re:Cognition Health
-
Kontakt:
- Antonio Iglesias, MD
- Telefonnummer: 312-971-3318
- E-mail: aiglesias@re-cognitionhealth.com
-
Ledende efterforsker:
- Antonio Iglesias, MD
-
-
Kentucky
-
Louisville, Kentucky, Forenede Stater, 40202
- Rekruttering
- Norton Children's Medical Center
-
Ledende efterforsker:
- Jaime Shoup, MD
-
Kontakt:
- Madeline McGinty-Holmes
- Telefonnummer: 502-629-5568
- E-mail: madeline.mcginty-holmes@louisville.edu
-
-
Michigan
-
Detroit, Michigan, Forenede Stater, 48202
- Aktiv, ikke rekrutterende
- Henry Ford Hospital
-
-
Minnesota
-
Roseville, Minnesota, Forenede Stater, 55102
- Rekruttering
- Minnesota Epilepsy Group, P.A.
-
Kontakt:
- Sarah Ellis, MD
- Telefonnummer: 651-377-8319
- E-mail: sellis@mnepilepsy.net
-
Ledende efterforsker:
- Stephanie Ahrens, MD
-
-
Nebraska
-
Omaha, Nebraska, Forenede Stater, 68114
- Rekruttering
- Children's Nebraska
-
Kontakt:
- Sookyong Koh, MD, PhD
- Telefonnummer: 773-929-4445
- E-mail: skoh@childrensnebraska.org
-
Ledende efterforsker:
- Sookyong Koh
-
-
New Jersey
-
Marlboro, New Jersey, Forenede Stater, 07746
- Rekruttering
- Tekton Research
-
Ledende efterforsker:
- Amor Mehta, MD
-
Kontakt:
- Aimee Kinlan
- Telefonnummer: 626-218-8294
- E-mail: aimee.kinlan@tektonresearch.com
-
-
New York
-
New York, New York, Forenede Stater, 10021
- Rekruttering
- Weill Cornell Medicine/New York Presbyterian Hospital
-
Kontakt:
- Lundy Santil
- Telefonnummer: Ext. 198 800-785-3150
- E-mail: ludny.saintil@thermofisher.com
-
Kontakt:
- Asim Shahid
- E-mail: los9075@med.cornell.edu
-
Ledende efterforsker:
- Asim Shahid, MD
-
New York, New York, Forenede Stater, 10016-4852
- Rekruttering
- NYU Comprehensive Epilepsy Center - BRANY - PPDS
-
Ledende efterforsker:
- Dana Price
-
-
North Carolina
-
Charlotte, North Carolina, Forenede Stater, 28211
- Rekruttering
- On-Site Clinical Solution
-
Ledende efterforsker:
- Robert Nahouraii
-
Kontakt:
- Ludny Saintil
- Telefonnummer: 198 800-785-3150
- E-mail: ludny.santil@thermofischer.com
-
Charlotte, North Carolina, Forenede Stater, 28207
- Rekruttering
- Atrium Health STRIVE Research
-
Kontakt:
- Jessica Lindley
- E-mail: Jessica.Lindley@atriumhealth.org
-
Ledende efterforsker:
- Ravi Singh, MD
-
Durham, North Carolina, Forenede Stater, 27705
- Rekruttering
- Duke University Medical Center
-
Kontakt:
- Muhammad Zafar, MD
- E-mail: muhammad.zafar@duke.edu
-
Ledende efterforsker:
- Muhammad Zafar, MD
-
Morrisville, North Carolina, Forenede Stater, 27560
- Rekruttering
- PPD Virtual-Science 37, Inc.
-
Ledende efterforsker:
- Antonio Iglesias, MD
-
Kontakt:
- Victoria Taylor
- Telefonnummer: 615-707-9148
- E-mail: victoria.taylor@science37.com
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forenede Stater, 19104
- Rekruttering
- Children's Hospital of Philadelphia
-
Ledende efterforsker:
- Eric Marsh, MD
-
-
Texas
-
Dallas, Texas, Forenede Stater, 75235
- Rekruttering
- Children's Health Specialty Center
-
Ledende efterforsker:
- Charuta Joshi
-
Houston, Texas, Forenede Stater, 77030
- Rekruttering
- UTHealth Houston
-
Kontakt:
- Antoinette Bernal-Tent
- Telefonnummer: 713-500-7105
- E-mail: Antoinette.BernalTent@uth.tmc.edu
-
Ledende efterforsker:
- Mary Koenig, MD
-
-
Utah
-
Salt Lake City, Utah, Forenede Stater, 84132
- Rekruttering
- Clinical Neurosciences Center
-
Ledende efterforsker:
- Angela Peters, MD
-
-
-
-
Andhra Pradesh
-
Hyderabad, Andhra Pradesh, Indien, 500082
- Rekruttering
- Nizams Institute of Medical Sciences
-
Ledende efterforsker:
- Surya Prabha Turaga
-
Hyderabad, Andhra Pradesh, Indien, 500081
- Rekruttering
- Yashoda Hospitals Hitec City
-
Ledende efterforsker:
- Lokesh Lingappa
-
-
Gujarat
-
Ahmedabad, Gujarat, Indien, 380054
- Rekruttering
- Royal Institute of Child Neurosciences
-
Ledende efterforsker:
- Nitish Vora
-
Surat, Gujarat, Indien, 395002
- Rekruttering
- Saachi Children Hospital
-
Ledende efterforsker:
- Ritesh Shah
-
-
Kerala
-
Calicut, Kerala, Indien, 673016
- Rekruttering
- Aster Malabar Institute of Medical Sciences Ltd
-
Ledende efterforsker:
- Smilu Mohanlal
-
-
-
-
-
Catanzaro, Italien, 88100
- Rekruttering
- Azienda Ospedaliera Universitaria Renato Dulbecco - AO Mater Domini
-
Ledende efterforsker:
- Antonio Gambardella
-
Florence, Italien, 50139
- Rekruttering
- Azienda Ospedaliero Universitaria A Meyer
-
Ledende efterforsker:
- Renzo Guerrini
-
Milan, Italien, 20133
- Rekruttering
- Fondazione IRCCS Istituto Neurologico Carlo Besta
-
Ledende efterforsker:
- Giuseppe Didato
-
Pavia, Italien, 27100
- Rekruttering
- Fondazione Istituto Neurologico Nazionale Casimiro Mondino IRCCS
-
Ledende efterforsker:
- Elena Tartara
-
-
Liguria
-
Genoa, Liguria, Italien, 16147
- Rekruttering
- IRCCS Istituto Giannina Gaslini
-
Ledende efterforsker:
- Maria Margherita Mancardi
-
Genoa, Liguria, Italien, 16132
- Rekruttering
- IRCCS Azienda Ospedaliera Metropolitan
-
Ledende efterforsker:
- Flavio Villani
-
-
Molise
-
Pozzilli, Molise, Italien, 86077
- Rekruttering
- IRCCS Istituto Neurologico Mediterraneo Neuromed
-
Ledende efterforsker:
- Alfredo D'Aniello
-
-
-
-
-
Beijing, Kina, 100045
- Rekruttering
- Beijing Children's Hospital, Capital Medical University - PIN
-
Ledende efterforsker:
- Hui Xiong
-
Beijing, Kina, 100034
- Rekruttering
- Peking University First Hospital - Changqiao Campus
-
Ledende efterforsker:
- Yuwu Jiang
-
Beijing, Kina, 100034
- Rekruttering
- Peking University First Hospital - Daxing Campus
-
Ledende efterforsker:
- Yuwu Jiang
-
Changchun, Kina, 130021
- Rekruttering
- The First Hospital of Jilin University
-
Ledende efterforsker:
- Jianmin Liang
-
Changsha, Kina, 410007
- Rekruttering
- Hunan Children's Hospital
-
Ledende efterforsker:
- Sai Yang
-
Chengdu, Kina, 610041
- Rekruttering
- West China Second University Hospital, Sichuan University - Huaxi Campus
-
Ledende efterforsker:
- Rong Luo
-
Chengdu, Kina, 610073
- Rekruttering
- Chengdu Women's and Children's Central Hospital
-
Ledende efterforsker:
- Li Yan
-
Chongqing, Kina, 400014
- Rekruttering
- Children's Hospital of Chongqing Medical University
-
Ledende efterforsker:
- Li Jiang
-
Guangzhou, Kina, 510260
- Rekruttering
- The Second Affiliated Hospital of Guangzhou Medical University
-
Ledende efterforsker:
- Xiaorong Liu
-
Guiyang, Kina, 550004
- Rekruttering
- The Affiliated Hospital of Guizhou Medical University
-
Ledende efterforsker:
- Rong Ai
-
Jinan, Kina, 250012
- Rekruttering
- Qilu Hospital of Shandong University
-
Ledende efterforsker:
- Baomin Li
-
Nanchang, Kina, 330006
- Rekruttering
- Jiangxi Provincial Children's Hospital
-
Ledende efterforsker:
- Yong Chen
-
Shenzhen, Kina, 518000
- Rekruttering
- Shenzhen Children's Hospital
-
Ledende efterforsker:
- Dezhi Cao
-
Wuhan, Kina, 430015
- Rekruttering
- Wuhan Children's Hospital
-
Ledende efterforsker:
- Dan Sun
-
Xi'an, Kina, 710004
- Rekruttering
- The Second Affiliated Hospital of Xi'an Jiaotong University
-
Ledende efterforsker:
- Lin Yang
-
Xuzhou, Kina, 221006
- Rekruttering
- Xuzhou Children's Hospital
-
Ledende efterforsker:
- Xiaoming Liu
-
-
Hunan
-
Changsha, Hunan, Kina, 410008
- Rekruttering
- Xiangya Hospital Central South University
-
Ledende efterforsker:
- Jing Peng
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Kina, 200062
- Rekruttering
- Children's Hospital of Shanghai
-
Ledende efterforsker:
- Simei Wang
-
-
-
-
Lesser Poland Voivodeship
-
Krakow, Lesser Poland Voivodeship, Polen, 30-363
- Rekruttering
- Centrum Medyczne Plejady Magdalena Celinska
-
Ledende efterforsker:
- Marta Zolnowska, MD
-
-
Lower Silesian Voivodeship
-
Wroclaw, Lower Silesian Voivodeship, Polen, 50-414
- Rekruttering
- Premium Clinic Wrocław Centrum Medyczne
-
Ledende efterforsker:
- Monika Sluzewska-Niedzwiedz
-
-
Masovian Voivodeship
-
Warsaw, Masovian Voivodeship, Polen, 02-829
- Rekruttering
- Neurosphera
-
Ledende efterforsker:
- Beata Zwolinska
-
-
-
-
-
Bucharest, Rumænien, 050098
- Rekruttering
- Emergency University Hospital
-
Ledende efterforsker:
- Ioana Raluca Mindruta
-
Bucharest, Rumænien, 041408
- Rekruttering
- Centrul National Clinic De Recuperare Neuropsihomotorie Copii Robanescu-Padure
-
Ledende efterforsker:
- Madalina Leanca
-
Iași, Rumænien, 700309
- Rekruttering
- Sf. Maria Children Emergency Clinical Hospital Iasi
-
Ledende efterforsker:
- Ioana Grigore
-
-
-
-
-
Belgrade, Serbien, 11000
- Rekruttering
- Mother and Child Health Care Institute of Serbia Dr Vukan Cupic
-
Ledende efterforsker:
- Biljana Vucetic Tadic
-
Belgrade, Serbien, 11000
- Rekruttering
- Childrens University Hospital
-
Ledende efterforsker:
- Dimitrije Nikolic
-
Niš, Serbien, 18 000
- Rekruttering
- University Clinical Center Nis
-
Ledende efterforsker:
- Tatjana Tosic
-
Novi Sad, Serbien, 21000
- Rekruttering
- Children and Youth Health Care Institute of Vojvodina
-
Ledende efterforsker:
- Tatjana Redzek Mudrinic
-
-
-
-
-
Barcelona, Spanien, 08025
- Rekruttering
- Hospital de La Santa Creu i Sant Pau
-
Ledende efterforsker:
- Alba Sierra-Marcos
-
Barcelona, Spanien, 08035
- Rekruttering
- Hospital Universitario Vall d'Hebron - PPDS
-
Ledende efterforsker:
- Manuel Toledo Argany
-
Madrid, Spanien, 28009
- Rekruttering
- Hospital Infantil Universitario Niño Jesus - PIN
-
Ledende efterforsker:
- Victor Soto Insuga
-
Málaga, Spanien, 29010
- Rekruttering
- Hospital Regional Universitario de Malaga - Hospital General
-
Ledende efterforsker:
- Pedro Serrano
-
Pamplona, Spanien, 31008
- Rekruttering
- Hospital Universitario de Navarra
-
Ledende efterforsker:
- Sergio Aguilera Albesa
-
Seville, Spanien, 41013
- Rekruttering
- Centro de Neurologia Avanzada
-
Ledende efterforsker:
- Juan Jesús Rodríguez Uranga, MD
-
-
-
-
-
Ortahisar, Tyrkiet (Türkiye), 61080
- Rekruttering
- Karadeniz Teknik Universitesi Farabi Hastanesi
-
Ledende efterforsker:
- Ali Cansu
-
-
Eskişehir
-
Odunpazari, Eskişehir, Tyrkiet (Türkiye), 26040
- Rekruttering
- Eskisehir Osmangazi Universitesi Saglik Uygulama ve Arastirma Hastanesi
-
Ledende efterforsker:
- Kursat Carman
-
-
-
-
Hajdú-Bihar
-
Debrecen, Hajdú-Bihar, Ungarn, 4032
- Rekruttering
- Debreceni Egyetem Klinikai Kozpont Nagyerdei Campus
-
Ledende efterforsker:
- Monika Bessenyei
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Key Inclusion Criteria:
-
Males or females, ages ≥2 to ≤55 years, at the time of Screening.
-
Participant/parent/legal authorized representative (LAR) willing and able to give written informed consent/assent.
-
Diagnosis of LGS, including:
- Evidence of at least one type of countable major motor seizure.
- History of electroencephalogram (EEG) consistent with LGS (abnormal background activity, and one of the following: 1) slow spike-wave discharges [<2.5 Hz], or 2) paroxysmal fast activity during sleep).
- Abnormal cognitive development.
- Onset of seizures at 11 years of age or younger.
Key Exclusion Criteria:
- Known sensitivity, allergy, or previous exposure to clemizole HCl.
- Known history of long QT syndrome or any significant history of a serious abnormality of the electrocardiogram (ECG) (e.g., recent myocardial infarction, clinically significant arrhythmia).
- Family history of sudden cardiac death, unexplained death, or death from a primary dysrhythmia potentially associated with QT prolongation in any family member.
- Seizures secondary to illicit drug or alcohol use, infection, neoplasm, demyelinating disease, degenerative neurological disease, or progressive central nervous system disease, metabolic illness, recent anoxic episode within the last 6 months requiring resuscitation, or progressive degenerative disease or any other condition, which in the opinion of the investigator, could affect seizure control.
- Epilepsy surgery planned during the study or epilepsy surgery within 6 months prior to Screening.
- Concomitant use of fenfluramine.
- Prior or concomitant use of lorcaserin.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Tredobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Placebo komparator: Placebo
Participants will receive their first dose of study drug following randomization. |
Placebo will be administered as an oral solution. |
|
Eksperimentel: Double-blind clemizole HCl
Participants will receive their first dose of study drug following randomization. |
Clemizole HCl will be administered as an oral solution.
Andre navne:
|
|
Eksperimentel: Open-label clemizole HCl
Eligible participants who complete the DB Period will have the option to continue in the OLE Period, during which they will receive clemizole HCl for up to 3 years. |
Clemizole HCl will be administered as an oral solution.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Percent Change in CMMS-28
Tidsramme: From Baseline Period up to 16 weeks
|
Percent change in CMMS-28 from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Proportion of Participants with ≥50% Reduction in CMMS-28
Tidsramme: From Baseline Period up to 16 weeks
|
Proportion of participants with ≥50% reduction in CMMS-28 from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Percent Change in CMMS-28 Seizure-free Days
Tidsramme: From Baseline Period up to 16 weeks
|
Percent change in CMMS-28 seizure-free days from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Clinical Global Impression of Change (CGI-C) Score
Tidsramme: Week 16
|
CGI-C score at the end of the DB Period |
Week 16
|
|
Caregiver Global Impression of Change (CaGI-C) Score
Tidsramme: Week 16
|
CaGI-C score at the end of the DB Period |
Week 16
|
|
Caregiver Global Impression of Change in Seizure Intensity/Duration (CaGI-CSID) Score
Tidsramme: Week 16
|
CaGI-CSID score at the end of the DB Period |
Week 16
|
|
Change in Quality of Life Inventory (QI)-Disability Score
Tidsramme: From Baseline Period up to 16 weeks
|
Change in QI-disability score from Baseline to the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Percent Change per 28 Days in the Number of Seizure Free Days
Tidsramme: From Baseline Period up to 16 weeks
|
Percent change per 28 days in the number of seizure-free days (based on all seizure types) from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Percent Change in CMMS-28
Tidsramme: From Baseline Period up to 12 weeks
|
Percent change in CMMS-28 from the Baseline Period through the end of the DB Maintenance Phase only |
From Baseline Period up to 12 weeks
|
|
Proportion of Participants with ≥50% Reduction in CMMS-28
Tidsramme: From Baseline Period up to 12 weeks
|
Proportion of participants with ≥50% reduction in CMMS-28 from the Baseline Period through the end of the DB Maintenance Phase only |
From Baseline Period up to 12 weeks
|
|
Incidence of Treatment-Emergent Adverse Events (TEAEs)
Tidsramme: From the first dose administration of study drug up to end of the study, approximately up to 172 weeks
|
Incidence of TEAEs will be compared among the treatment groups |
From the first dose administration of study drug up to end of the study, approximately up to 172 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Studieleder: Amit Ray, MD, Harmony Biosciences Management, Inc.
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Epileptiske syndromer
- Neurologiske manifestationer
- Hjernesygdomme
- Sygdomme i centralnervesystemet
- Sygdomme i nervesystemet
- Genetiske sygdomme, medfødte
- Epilepsi
- Medfødte, arvelige og neonatale sygdomme og abnormiteter
- Patologiske tilstande, tegn og symptomer
- Tegn og symptomer
- Anfald
- Lennox Gastaut syndrom
Andre undersøgelses-id-numre
- EPX-100-003
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .